Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex's Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes | Business Wire
CRISPR for Type 1 & 2 Diabetes Identification and Treatment | IDT
News: First CRISPR Therapy for Type 1 Diabetes Set to Enter Clinical Trial - CRISPR Medicine
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex's Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes
CRISPR-based genome editing in primary human pancreatic islet cells | Nature Communications
Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines - ScienceDirect
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM
Induced pluripotent stem cells and CRISPR reversed diabetes in mice
CRISPR/Cas based gene editing: marking a new era in medical science | SpringerLink
Solved Questions What can CRISPR do for type 1 diabetes? | Chegg.com
Cells | Free Full-Text | Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect
Type-2 Diabetes and Gene Therapy: The Promise of CRISPR Gene Therapy in type-2 Diabetes Mellitus - Open Access Pub
Advances in CRISPR therapeutics | Nature Reviews Nephrology
A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells: Molecular Therapy - Nucleic Acids
Salk scientists modify CRISPR to epigenetically treat diabetes, kidney disease, muscular dystrophy - Salk Institute for Biological Studies
Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells - ScienceDirect
The Most Innovative Ways to Use CRISPR | OpenMind
Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes | Nature Metabolism
CRISPR-Cas9 successfully reverses obesity in mice
Strategies for durable β cell replacement in type 1 diabetes | Science
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges - ScienceDirect
Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs, more - The Niche
Reversing diabetes with CRISPR and patient-derived stem cells | Fierce Biotech
Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
CRISPR/Cas9 system - a revolution in gene editing
